|
nasdaq:arql
|
14697
|
Aug 26th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 26th, 2020 08:48AM
|
Aug 26th, 2020 08:48AM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 25th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 25th, 2020 12:42PM
|
Aug 25th, 2020 12:42PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 24th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 24th, 2020 08:37AM
|
Aug 24th, 2020 08:37AM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 23rd, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 23rd, 2020 02:08PM
|
Aug 23rd, 2020 02:08PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 22nd, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 22nd, 2020 01:17PM
|
Aug 22nd, 2020 01:17PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 21st, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 21st, 2020 11:02AM
|
Aug 21st, 2020 11:02AM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 20th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 19th, 2020 10:13PM
|
Aug 19th, 2020 10:13PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 19th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 19th, 2020 01:37PM
|
Aug 19th, 2020 01:37PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 18th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 18th, 2020 02:21PM
|
Aug 18th, 2020 02:21PM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:arql
|
14697
|
Aug 17th, 2020 12:00AM
|
ArQule
|
1.8K
|
77.00
|
Open
|
Biotechnology
|
Aug 17th, 2020 09:00AM
|
Aug 17th, 2020 09:00AM
|
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
Our mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need.
With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications and its shareholders with a focused, highly efficient and cost effective research and development strategy.
ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field.
|
Open
|
|
Open
|
One Wall Street
|
Burlington
|
MA
|
US
|
01803
|
|
ArQule
|
Health Care
|
Pharmaceuticals & Biotechnology
|